For women with mild heart failure, device therapy is an extremely attractive option to prevent progression of the disease. A new study found that women with mild heart disease who had a cardiac resynchronization device combined with a defibrillator (CRT-D) implanted had a 70 percent reduction in heart failure alone and a 72 percent reduction in death from any cause. This is the first study in which a heart failure therapy has proven more effective in women than in men.